Fatty acid (FA) compositions in tissues are related to metabolic disorders and cell dysfunction (1, 2). Insulin resistance and hyperglycemia are improved by the modification of hepatic FA composition (1). Moreover, epidemiological and clinical evidence suggests a significant inverse association between the long-term intake of polyunsaturated FA/serum polyunsaturated FA levels and mortality from coronary heart disease (CHD) (3-10), as well as the preventive effects of eicosapentaenoic acid (EPA) on CHD (11, 12) . FA compositions in tissues are derived from diet, de novo synthesis and in vivo desaturation by desaturase enzymes. However, the association among metabolic diseases, FA composition of the red blood cell (RBC) membranes and desaturase factors of FA is unclear.
Fatty acid (FA) compositions in tissues are related to metabolic disorders and cell dysfunction (1, 2) . Insulin resistance and hyperglycemia are improved by the modification of hepatic FA composition (1) . Moreover, epidemiological and clinical evidence suggests a significant inverse association between the long-term intake of polyunsaturated FA/serum polyunsaturated FA levels and mortality from coronary heart disease (CHD) (3) (4) (5) (6) (7) (8) (9) (10) , as well as the preventive effects of eicosapentaenoic acid (EPA) on CHD (11, 12) . FA compositions in tissues are derived from diet, de novo synthesis and in vivo desaturation by desaturase enzymes. However, the association among metabolic diseases, FA composition of the red blood cell (RBC) membranes and desaturase factors of FA is unclear.
The fatty acid desaturase (FADS) genes FADS1 and FADS2 affect the synthesis of FAs and an individual's serum lipid profile. Various studies have indicated that single nucleotide polymorphisms (SNPs) in the FADS1 and FADS2 genes have an effect on FA composition (13) . For example, a recent genome-wide association (GWA) study of a Korean population revealed that carriers of the minor alleles rs174537 (flap structure-specific endonuclease; near FADS1), rs174575 (FADS2), rs2727270 (FADS2), and 1000778 (FADS3) had lower arachidonic acid (AA) levels than individuals who carried the homo-
Genetic Variants of the Fatty Acid Desaturase Gene Cluster
Are Associated with Plasma LDL Cholesterol Levels in Japanese Males (14) . Another genome-wide study in European adolescents suggested that serum FA levels are correlated with specific alleles in the FADS gene cluster (15) . The minor alleles of the SNPs rs174546, rs968567, rs174570, rs174572, rs2072114, rs174589, rs174602, rs174611, rs526126, and rs174616 were associated with low AA levels. Furthermore, the major alleles of 9 SNPs, rs174537, rs174545, rs174546, rs174553, rs174556, rs174561, rs99780, rs174575 and rs174583, were significantly associated with higher serum AA levels than were minor alleles in a Tangier Island population in Virginia (16) . In contrast, the minor alleles for rs174568, rs174570 and rs2524299 were significantly associated with higher AA levels. In German and Italian populations; several SNPs within the FADS1 and FADS2 genes were shown to be associated with the levels of AA in RBC membranes and serum phospholipids (17, 18) .
Additionally, the effects of the SNPs in the FADS genes on serum lipid markers have been examined. The results of recent GWA studies indicate that minor alleles of FADS1 and FADS2 are associated with (1) lower total cholesterol (TC) levels, (2) lower low-density lipoprotein cholesterol (LDL-C) levels, (3) lower high-density lipoprotein cholesterol (HDL-C) levels, and (4) higher triglyceride (TG) levels in several populations (8, 9, (19) (20) (21) . A study of polymorphisms in a Korean population also showed that rs174537 T carriers of SNPs near FADS1 have lower LDL-C concentrations than do non-carriers. However, the associations among hyperlipidemia, FA levels and FADS variants have not been well studied in the Japanese population. There are highly significant genetic differences between the Japanese and Korean populations, such as the frequency of immunoglobulin G haplotypes (22) .
Furthermore, CHD closely related with dyslipidemia remains a major cause of death worldwide (23) (24) (25) (26) . It is well known that a high LDL-C level and a high arteriosclerotic index such as the LDL-C/TC ratio are major risk factors for CHD (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) . Given that hyperlipidemia and high atherosclerosis indexes have been reported to be independent risk factors for CHD in the Japanese population (30, 31, (33) (34) (35) (36) , it is necessary to investigate the relationship between the serum lipid profile and the FA composition as well as the FADS genes.
MATERIALS AND METHODS

Subjects.
We recruited 150 Japanese men, 40 to 60 y old, who had a regular health checkup at Fukuoka Institute of Occupational Health (37) for the study. Among the 150 initially recruited subjects, 13 were excluded because they did not conform to the study protocol (n52); were missing data for weight and waist circumference (n52) or genotyping (n53); or had a serum TG level 400 mg/dL (n56). Consequently, 137 subjects were included in this study. The subjects were informed of the details of the study, and we assessed their comprehension of the purposes and procedures of the study before they signed the consent form. The study protocol adhered to the Japanese Government's Ethical Guidelines Regarding Epidemiological Studies, in accordance with the Declaration of Helsinki, and was approved by the Institutional Review Board of Human Genome Research Ethics at the Institute of Life and Environmental Science for Human Life, Ochanomizu University, Japan.
Measurement of clinical characteristics. All of the sub- jects completed a standard questionnaire that included smoking, alcohol consumption and a medical history of angina pectoris, diabetes, hyperlipidemia, hypertension, myocardial infarction and cerebral stroke. The evaluated clinical characteristics of the subjects included their age (y), height (cm), weight (kg), and waist circumference (cm) and levels of serum TG (mg/dL), TC (mg/dL), HDL-C (mg/dL), fasting plasma glucose (mg/ dL), hemoglobin A1C (HbA1C) (%) and total protein (g/ dL). We determined the subjects' age and measured their height, weight and waist circumference. The body mass index (BMI) was calculated as body weight in kilograms divided by height in square meters (kg/m 2 ). The subjects were asked to fast overnight, after which blood samples were collected in ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA2Na)-treated tubes for FA composition measurement and FADS genotyping. Additional blood samples were collected in an anticoagulant film-coated tube and in a glycolytic inhibitor-treated tube for multiple biochemical assays.
General clinical measurements. Serum and plasma were obtained by centrifugation at 1,000 3g for 20 min at 4˚C. The biochemical marker levels, with the exception of HbA1C, were measured using a BioMajesty BM-2250 clinical biochemistry analyzer (JEOL, Tokyo, Japan). The following commercially available kits were used for each biochemical measurement: Determiner L TG (Kyowa Medex, Tokyo, Japan) for triglycerides, Determiner L TC (Kyowa Medex) for TC, Choletest N HDL (Sekisui Chemical, Tokyo, Japan) for HDL-C, Shikarikid GLU (Kanto Chemical, Tokyo, Japan) for the enzymatic measurement of fasting blood glucose, Ekudia XL "Eiken" TP (Eiken Chemical, Tokyo, Japan) for total protein measurement by the biuret method, and Ekudia XL "Eiken" ALB-BCG (Eiken Chemical) for albumin measurement by the BCG method. HbA1C was measured using an automatic glycohemoglobin analyzer HLC-723G8 (Tosoh, Tokyo, Japan). Serum LDL-C was calculated indirectly from the Averages of the data for 137 persons are summarized. values of TG, TC, and HDL-C using the Friedewald equa-
The LDL-C/TC and LDL-C/HDL-C ratios and the non-HDL cholesterol (non-HDL-C) levels were calculated from each cholesterol level.
Genotyping of FADS gene polymorphisms.
Based on HapMap project data (http://www.hapmap.org), four SNPs, rs174553 (FADS1, position 61331734, assay ID c_2575538_1_), rs174546 (FADS1, position 61326404, assay ID c_2268976_1_), rs99780 (FADS2, position 61353209, assay ID 2268961_20), and rs174583 (FADS2, position 61366326, assay ID c_2268952_20), were selected and genotyped using the TaqMan SNP allelic discrimination method with an ABI 7300 system (Applied Biosystems, Foster City, CA). Genotyping was performed at the Institute of Life and Environmental Science for Human Life. Genomic DNA was extracted from 5 mL blood samples using a commercially available DNA extraction kit for blood samples (Takara, Kyoto, Japan) according to the manufacturer's instructions.
Assessment of fatty acid composition. To assess the FA composition of RBC membranes, the RBC membranes were extracted and their buffy coats were eliminated.
The lower layer phase was resuspended with ice-cold phosphate-buffered saline (154 mm NaCl, 3 mm KCl, 8 mm Na2HPO4, 1.7 mm KH2PO4), and after gentle mixing, the sample was centrifuged at 400 3g for 5 min at 4˚C and washed three times. The RBC phase was resuspended by dripping into Tris-HCl buffer (5 mm 2-amino-2-hydroxymethyl-propane-1,3-diol-HCl, 1 mm EDTA2Na, 2 mm phenylmethylsulfonyl fluoride, pH 7.8) while stirring. The RBC membranes were isolated by centrifugation at 20,000 3g for 20 min at 4˚C. The membranes were washed five times using Tris-HCl buffer. The pellet was resuspended in 1 mL normal saline (0.9% NaCl).
A sample of 0.5 mL RBC suspension was used for membrane FA analysis. For lipid extraction from RBC membranes, RBC membranes (1 mL) were prepared with chloroform-methanol (1/2, v/v) according to the method of Folch et al. (38) with some modifications. The RBC membranes were vortexed with a solution of chloroform-methanol and 0.9% KCl, centrifuged at 3,000 3g for 10 min at 4˚C, and then extracted with chloroform-methanol. The organic phase was collected and evaporated to dryness. To analyze several FA levels, the lipid extract was methyl esterified with methanol and acetyl chloride. After esterification, the methanol and acetyl chloride were vortexed with hexane. The hexane layers were removed, transferred to new test tubes and washed with 2% potassium bicarbonate. The hexane was evaporated, and the FA methyl esters were redissolved in hexane.
To detect multiple FA peaks, FA methyl esters were separated using a 50 m Select FAME capillary column (Agilent Technologies, Santa Clara, CA) and a GC-2010 Plus gas chromatograph with a flame-ionization detector (Shimadzu, Kyoto, Japan). Authentic standards (Sigma Aldrich, St. Louis, MO and Nu-Chek Prep, Elysian, MN) were used to facilitate the identification and quantification of the FA methyl ester peaks. The individual FA levels were calculated as the relative percentages of the 22 types of FA. The measured FA levels were expressed as percentages.
Among the 22 types of FA that were analyzed, four major types, linoleic acid (LA, 18:2n-6), g-linolenic acid (GLA, 18:3n-6), dihomo-g-linolenic (DGLA, 20:3n-6) acid, and arachidonic acid (AA, 20:4 n-6), were considered n-6 FAs. The intra-assay CVs of LA, GLA, DGLA, and AA were 0.48%, 0.74%, 0.51%, and 0.51%, respectively. The FADS1 desaturation index was estimated as the ratio of AA to DGLA, and the FADS2 desaturation index was estimated as the ratio of GLA to LA. Total FADS activity was estimated as the ratio of AA to LA. The desaturation index represents the ratio of the level of product FA to its precursor, as determined by the integrated area under the gas chromatogram peak and estimated by only the apparent FA level. Alternatively, these values can be considered apparent indexes instead of the true activities. Statistical analysis. Biochemical data are shown as means6SD. Data were analyzed by one-way ANOVA. To examine the relationship between genotypes and biochemical data for the study subjects, the Mann-Whitney U test was conducted. The Hardy-Weinberg equilibrium test was used to evaluate the consistency between the observed and expected genotype frequencies. Moreover, to examine the relationship between the alleles of each SNP and the prevalence of hyperlipidemia (39) , multiple regression analyses were conducted; possible confounding factors, such as the relative FA level (AA; C20:4 n-6), age, height, weight, BMI, waist circumference (abdominal obesity), TG, HDL-C, non-HDL-C level, fasting blood glucose, HbA1C, total protein, past history data, smoking, and alcohol consumption, were entered as independent variables. A two-sided p value of ,0.05 was considered to be statistically significant. These statistical analyses were performed with SPSS (Statistical Package for the Social Sciences) version 20.0 (IBM Corporation, New York, NY).
RESULTS
Clinical characteristics and genotype distribution in the study subjects
The clinical characteristics and medical histories of the 137 subjects are shown in Tables 1 and 2 , respectively. No extreme difference for any clinical characteristic between our subjects and most Japanese males was found (40) . Table 3 shows the genotype distribution and nucleotide frequencies in this study population. The allele frequencies were as follows: FADS1 A.G rs174553, G50.4380; FADS1 C.T rs174546, T50.4343; FADS2 C.T rs99780, T50.4380; and FADS2 C.T rs174583 T50.4781. The allele frequen- cies of the examined SNPs in the current population were in Hardy-Weinberg equilibrium, although they differed from those reported for other populations (16, 41) . Tables 4-7 show the correlations between each FADS genetic polymorphism examined and the biochemical parameters. The arachidonic acid (AA) levels in the carriers of the homozygous genotype for the minor alleles tended to be lower compared with the carriers of the major alleles. However, no significant differences were observed in the fatty acid levels among the three genotypes for any SNP. Furthermore, compared with the subjects who were homozygous for the major allele 1 heterozygous, the subjects who were homozygous for the minor allele had significantly lower AA levels and AA/LA ratios. Two SNPs, rs174553 in the FADS1 gene and rs99780 in the FADS2 gene, were in perfect linkage disequilibrium.
Associations between the genotype and the biochemical parameters
Moreover, homozygotes for the minor alleles of FADS1 A.G rs174553, FADS1 C.T rs174546 and FADS2 C.T rs99780 had lower serum LDL-C concentrations by approximately 20 mg/mL and lower LDL-C/TC ratios by approximately 0.05 than individuals with the other genotypes. There were no significant differences in LDL-C levels between the heterozygotes and those homozygous for the minor allele for any SNP. The carriers of the FADS2 homozygous for the minor allele C.T rs174583 also had lower LDL-C/TC ratios and higher TG levels than carriers of the homozygous for the major allele, while the FADS2 C.T rs174583 genotype had no effect on LDL-C levels. Table 8 shows the results of the multiple regression analysis that was used to identify the factors associated with serum LDL-C level. Compared with the other alleles, those homozygous for the minor alleles of three SNPs (FADS1 A.G rs174553, FADS1 C.T rs174546 and FADS2 C.T rs99780) were found to have a sig- nificant effect on lowering hyperlipidemia (R 2 50.50, b520.20, p50.009). The multiple regression analysis also showed that the serum TG level and non-HDL-C had a significant influence on the serum LDL-C level, while no effects of the AA level, smoking or alcohol consumption on LDL-C level were found in this population.
DISCUSSION
Our study is the first to investigate the association of the variants of the FADS gene with both FA composition and serum lipid biomarkers in Japanese men. Our results indicated that FADS1 and FADS2 genotypes tend to be associated with the level of AA relative to the total FA composition in a Japanese population. This finding is comparable to the results of previous studies that have reported high AA concentrations in association with the major allele for the relevant SNPs in other populations (14) . Individuals who were homozygous for the minor alleles exhibited lower AA/LA ratios, which can be considered as surrogates for FADS activity, relative to carriers of the major allele in all four positions; however, the differences were not significant. The lack of significant differences in the AA level may be due to the small sample size and the diet. Specifically, population differences in diet might affect the weak association of the FA composition of the RBC membrane with these gene variants.
The examined SNPs in the FADS gene, specifically rs174553, rs99780, rs174583, and rs174546, are located in untranslated regions. Recent functional analyses indicated that the haplotypes carrying the rs174546 minor allele were associated with lower FADS1 activity, suggesting that this SNP is in linkage disequilibrium with a functional SNP within FADS1. In contrast, the rs968567 minor allele was associated with higher FADS2 activity (15) . These results suggest that rare alleles of several SNPs in the FADS gene cluster are associated with higher FADS2 activity and lower FADS1 activity. However, the associations of the other SNPs in this study with FADS activities remain unclear.
The FA levels in RBC membranes were examined based on a previous report showing that some components of the FA in the RBC membrane are suitable biomarkers of long-term dietary intake (42) . On the other hand, it remains controversial whether the FA content in the RBC membrane is less sensitive to the acute effects of dietary intake than the FA content in the serum (42, 43) . However, the composition of RBC phospholipids reflects slow and steady exchange with plasma lipid pools (43) . Therefore, further investigation including long-term dietary fatty acid is necessary to identify factors that directly influence the fatty acid composition in the RBC. Moreover, the homozygous genotype for the minor alleles of rs174553, rs174546 and rs99780 were associated with low serum LDL-C levels and LDL-C/TC ratios. This finding is consistent with a previous report in a Korean population (14) showing that individuals with the GG genotype of rs174537 had higher LDL-C levels. In the Japanese men, the differences in the LDL-C levels among of the FADS genotypes observed were approximately 20 mg/dL, which was of considerable clinical importance, unlike the previous study (14) . For the Japanese population, the genotypes of rs174553, rs174546 and rs99780 would be more influential for serum lipid profiles than the diversities of their past history data, smoking, or alcohol consumption in the population (Table 8) .
Other investigations have also found a consistent association between FADS1-FADS2 gene cluster SNPs and low levels of LDL-C and HDL-C, suggesting that alterations in desaturase activities also affect plasma lipoprotein levels (3, 8, 9, 20, 44, 45) . A possible mechanism has been suggested: that a lower concentration of AA and ARA/LA ratio in minor allele carriers results in comparative increased membrane fluidity, thus increasing LDL-C receptor recycling and resulting in decreased LDL-C (44) . Moreover, the present findings between AA levels in the RBC membranes and LDL-C could also suggest a possible role of AA in lipid peroxidation. However, at present, it is not known how desaturase (i.e., FADS1, FADS2, or both) is involved in these associations.
Additionally, rs174553, rs174546 in the FADS1 gene and rs99780 in the FADS2 gene had similar patterns of genetic variation in this population, and were in linkage disequilibrium; thus, the carriers of several genotypes were identical in three SNP positions (Tables 4-6 ).
Another possible association of the SNPs in this study with the LDL-C levels can be due to linkage disequilibrium in this population. Although the linkage disequilibrium of the FADS genes in this study could not be analyzed, previous studies have showed that the SNPs in the FADS genes are in mutual linkage disequilibrium in various populations (16, 17) . For example, Mathias et al. (16) identified a considerable region of linkage disequilibrium related to the FADS genes, which extend 43 kb from rs174537 on chromosome 11 to rs99780 in intron 1 of FADS2 and include rs174553, rs99780, rs174583 and rs174546. Moreover, Schaeffer et al. (17) reported a highly preserved linkage disequilibrium block, with a D′ of 0.9 (D′: scale of linkage disequilibrium, 0|D′|1), between the consecutive SNPs covering a 48-kb genomic region from position 61324329 (rs174544) to position 61372379 (rs174589) on chromosome 11, covering the examined SNPs (rs174553, rs99780, rs174583, and rs174546). Although the possible roles of the FADS genes in modulating LDL-C concentration are not well understood, it is possible that there is linkage disequilibrium between the FADS genes and other as-yet-unidentified genes that contribute to hyperlipidemia as well as FA composition. Further studies are needed to clarify the genes that are related to hyperlipidemia and are in linkage disequilibrium with the FADS genes.
Several limitations of our study should be addressed. First, there were no data available regarding any medications taken by the subjects. Therefore, we had to consider this confounder based on data related to the medical history. Second, we did not use random sampling when recruiting the subjects, which might have led to selection bias. Further investigation including long-term dietary FA is necessary to identify factors that directly influence the FA composition in the RBC.
In conclusion, our results suggest that the three genotypes in FADS genes tended to be associated with AA levels in this Japanese population. In contrast, the homozygote for the minor alleles for the FADS genes have a low serum LDL-C level compared with the major allele carriers. These results indicate that the appropriate management of serum LDL-C levels depending on genetic predisposition in FADS1 and FADS2 genotypes should be encouraged.
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